Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 11, 2015Leukemia & lymphoma/Leukemia and lymphoma

Economic impact of disease progression following front-line therapy in classical Hodgkin lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

CYChristopher A. YasenchakWTWan-Yu TsengMYMark Yap

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yasenchak et al. (2015) studied this question.

synapsesocial.com/papers/6a79e49d4c448619ca0ded03https://doi.org/10.3109/10428194.2015.1030639
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Standard therapy of advanced Hodgkin lymphoma2009 · 85 citations
  2. 2Cost Effectiveness and Screening Interval of Lipid Screening in Hodgkin's Lymphoma Survivors2009 · 28 citations